Ch14.18-IL2 induces anti-melanoma activity in a SCID –xenograft model [53] and in conventional mice bearing syngeneic tumors expressing GD2 (B78 melanoma) [54,55], and anti-NBL activity in conventional mice bearing the GD2+ NXS2 NBL [56,57]. This evidence concerns the gene IL2 and melanoma.